Vital Signs: 08 October 2009 – SIP
October 7, 2009
Sigma Pharmaceuticals Limited (SIP) said it fell short of the proposed $297 million it hoped to raise through an equity raising. The company made the announcement after completing the retail component, which saw over 50 million valid applications for shares representing around 32% of the total number of entitlements offered under the retail entitlement offer. Sigma said there was a shortfall of close to 110 million new shares not taken up under the retail entitlement offer.
Leave a Reply